SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID
F. Lanza et al., SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 (COX-2) WITH MK-0966 (250 MGQD) IS ASSOCIATED WITH LESS GASTRODUODENAL DAMAGE THAN ASPIRIN (ASA) 650 MG QID OR IBUPROFEN (IBU) 800 MG TID, Gastroenterology, 112(4), 1997, pp. 194-194